Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 301, Issue 1, 2011, Pages

  Flannigan, Kyle L ^a   McCoy, Kathy D ^a,b   Wallace, John L ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bacteria; Inflammation; Microflora; Mucosal defense; Repair; Ulcer

Indexed keywords

HYDROGEN SULFIDE; PYRIDOXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; EUKARYOTIC CELL; FECES; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROKARYOTIC CELL; SYNTHESIS;

ANIMALS; BACTERIA; COLITIS; COLON; FECES; GERM-FREE LIFE; HYDROGEN SULFIDE; MALE; MICE; RATS; RATS, WISTAR; VITAMIN B 6;

EID: 79959848869     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00105.2011     Document Type: Article

References (42)

1. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066-1071, 1996.
2. Babidge W, Millard S, Roediger W. Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis. Mol Cell Biochem 181: 117-124, 1998.
3. Blachier F, Davila A, Mimoun S, Benetti P, Atanasiu C, Andriamihaja M, Benamouzig R, Bouillaud F, Tom D. Luminal sulfide and large intestine mucosa: friend or foe? Amino Acids 39: 335-347, 2010.
4. Boughton-Smith NK, Wallace JL, Morris GP, Whittle BJ. The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol 94: 65-72, 1988.
5. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209, 1982.
6. Dewhirst FE, Chien CC, Paster BJ, Ericson RL, Orcutt RP, Schauer DB, Fox JG. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol 65: 3287-3292, 1999.
7. Distrutti E, Sediari L, Mencarelli A, Renga B, Orlandi S, Antonelli E, Roviezzo F, Morelli A, Cirino G, Wallace JL, Fiorucci S. Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther 316: 325-335, 2006.
8. Ekundi-Valentim E, Santos KT, Camargo EA, Denadai-Souza A, Teixeira SA, Zanoni CI, Grant AD, Wallace J, Muscará MN, Costa SK. Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat. Br J Pharmacol 159: 1463-1474, 2010.
9. Fiorucci S, Distrutti E, Cirino G, Wallace JL. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 131: 259-271, 2006.
10. Fiorucci S, Antonelli T, Distrutti E, Rizzo G, Mancarelli A, Orlandi S, Zanardo R, Renga B, Di Sante M, Morelli A, Cirino Wallace JL. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129: 1210-1224, 2005.
11. Fiorucci S, Orlandi S, Mencarelli A, Caliendo G, Santagada V, Distrutti E, Santucci L, Cirino G, Wallace JL. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol 150: 996-1002, 2007.
12. Freireich AW. Hydrogen sulfide poisoning: Report of two cases, one with fatal outcome, from associated mechanical asphyxia. Am J Pathol 22: 147-155, 1946.
13. Goubern M, Andriamihaja M, Nübel T, Blachier F, Bouillaud F. Sulfide, the first inorganic substrate for human cells. FASEB J 21: 1699-1706, 2007.
14. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: 527-531, 1997.
15. Kimura H. Hydrogen sulfide as a neuromodulator. Mol Neurobiol 26: 13-19, 2002.
16. Lagoutte E, Mimoun S, Andriamihaja M, Chaumontet C, Blachier F, Bouillaud F. Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta 1797: 1500-1511, 2010.
17. Levine J, Ellis CJ, Furne JK, Springfield J, Levitt MD. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 93: 83-87, 1998.
18. Levitt MD, Springfield J, Furne J, Koenig T, Suarez FL. Physiology of sulfide in the rat colon: use of bismuth to assess colonic sulfide production. J Appl Physiol 92: 1655-1660, 2002.
19. Li L, Rose P, Moore PK. Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 51: 169-187, 2011.
20. 2S in the gastrointestinal tract: still in search of a physiologic function. Antiox Redox Signal 12: 1135-1146, 2010.
21. Linden DR, Sha L, Mazzone A, Stoltz GJ, Bernard GE, Furne JK, Levitt MD, Farrugia G, Szurszewski JH. Production of the gaseous signal molecule hydrogen sulfide in mouse tissues. J Neurochem 106: 1577-1585, 2008.
22. Martin GR, McKnight GW, Dicay MS, Coffin CS, Ferraz JG, Wallace JL. Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Dig Liver Dis 42: 103-109, 2010.
23. Mathal JC, Missner A, Kugler P, Saparov SM, Zeidel ML, Lee JK, Pohl P. No facilitator required for membrane transport of hydrogen sulfide. Proc Natl Acad Sci USA 106: 16633-16638, 2009.
24. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803, 1989.
25. Picton R, Eggo MC, Merrill GA, Langman MJ, Singh S. Mucosal protection against sulphide: importance of the enzyme rhodanese. Gut 50: 201-205, 2002.
26. Roediger WE, Duncan A, Kapaniris O, Millard S. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis? Clin Sci (Lond) 85: 623-627, 1993.
27. Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MA, Geuking MB, Beutler B, Tedder TF, Hardt WD, Bercik P, Verdu EF, McCoy KD, Macpherson AJ. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325: 617-620, 2009.
28. Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 19: 59-69, 2007.
29. Srilatha B, Adaikan PG, Moore PK. Possible role for the novel gasotransmitter hydrogen sulphide in erectile dysfunction-a pilot study. Eur J Pharmacol 535: 280-282, 2006.
30. Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphydration in liver and kidney of the rat. Biochem J 206: 267-277, 1982.
31. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935, 2007.
32. Tannock GW. What immunologists should know about bacterial communities of the human bowel. Sem Immunol 19: 94-105, 2007.
33. Troen AM, Shea-Budgell M, Shukitt-Hale B, Smith DE, Selhub J, Rosenberg IH. B-vitamin deficiency causes hyperhomocyteinemia and vascular congnitive impairment in mice. Proc Nat Acad Sci USA 105: 12474-12479, 2008.
34. Wallace JL, Caliendo G, Santagada V, Cirino G. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br J Pharmacol 159: 1236-1249, 2010.
35. Wallace JL, Dicay M, McKnight W, Martin GR. Hydrogen sulfide enhances ulcer healing in rats. FASEB J 21: 4070-4076, 2007.
36. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol Gastrointest Liver Physiol 258: G527-G534, 1990.
37. Wallace JL, Vong L, McKnight W, Dicay M, Martin GR. Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology 137: 569-578, 2009.
38. Wallace JL. Building a better aspirin: gaseous solutions to a century-old problem. Br J Pharmacol 152: 421-428, 2007.
39. Wallace JL. Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. Antioxid Redox Signal 12: 1125-33, 2010.
40. 2S be the third endogenous gaseous transmitter? FASEB J 16: 1792-1798, 2002.
41. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocytemediated inflammation. FASEB J 20: 2118-2120, 2006.
42. 2S as a novel endogenous gaseous KATP channel opener. EMBO J 20: 6008-6016, 2001.